Tweet
<img alt="" height="1" width="1" />
TranS1 gets FDA approval for product
BusinessWeek
Medical device maker TranS1 Inc. said Thursday it received Food and Drug Administration clearance for a spinal implant system. Shares surged $1.13, or 35 percent, to $4.39 in premarket trading. TranS1 said it received clearance for the "AxiaLIF 1L+" ...
TranS1 gets FDA nod for new spine surgery deviceYTWHW
TranS1 Inc. Is Climbing Sharply On FDA NewsRTT News
TranS1 surges on 510(k) clearance. Walgreens acquires drugstore.comBioMedReports (subscription)
Nothing But Buzz -GlobeNewsWire (press release) -Becker's Orthopedic & Spine (press release)
all 18 news articles »
More...